- Home
- TNXP vs JZXN Comparison
TNXP vs JZXN Comparison
Compare TNXP & JZXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNXP
- JZXN
- Stock Information
- Founded
- TNXP 2007
- JZXN 2019
- Country
- TNXP United States
- JZXN China
- Employees
- TNXP N/A
- JZXN N/A
- Industry
- TNXP Biotechnology: Pharmaceutical Preparations
- JZXN Retail-Auto Dealers and Gas Stations
- Sector
- TNXP Health Care
- JZXN Consumer Discretionary
- Exchange
- TNXP Nasdaq
- JZXN Nasdaq
- Market Cap
- TNXP 272.0M
- JZXN 10.3M
- IPO Year
- TNXP N/A
- JZXN 2021
- Fundamental
- Price
- TNXP $40.87
- JZXN $1.16
- Analyst Decision
- TNXP Strong Buy
- JZXN
- Analyst Count
- TNXP 2
- JZXN 0
- Target Price
- TNXP $585.00
- JZXN N/A
- AVG Volume (30 Days)
- TNXP 720.7K
- JZXN 493.3K
- Earning Date
- TNXP 08-15-2025
- JZXN 09-08-2025
- Dividend Yield
- TNXP N/A
- JZXN N/A
- EPS Growth
- TNXP N/A
- JZXN N/A
- EPS
- TNXP N/A
- JZXN N/A
- Revenue
- TNXP $10,041,000.00
- JZXN $1,400,139.00
- Revenue This Year
- TNXP $11.66
- JZXN N/A
- Revenue Next Year
- TNXP $793.18
- JZXN N/A
- P/E Ratio
- TNXP N/A
- JZXN N/A
- Revenue Growth
- TNXP N/A
- JZXN N/A
- 52 Week Low
- TNXP $6.76
- JZXN $0.84
- 52 Week High
- TNXP $130.00
- JZXN $7.82
- Technical
- Relative Strength Index (RSI)
- TNXP 62.15
- JZXN 35.46
- Support Level
- TNXP $33.20
- JZXN $0.94
- Resistance Level
- TNXP $43.80
- JZXN $1.06
- Average True Range (ATR)
- TNXP 2.63
- JZXN 0.09
- MACD
- TNXP 0.31
- JZXN 0.09
- Stochastic Oscillator
- TNXP 77.43
- JZXN 88.70
About TNXP Tonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.
About JZXN Jiuzi Holdings Inc.
Jiuzi Holdings Inc operates as a franchise under the brand name Jiuzi. It sells new energy vehicles in third-fourth tier cities in China. The firm also sells plug-in electric vehicles on demand from vehicle buyers. Its operating segments are propretaey product; and resale of sourced Equipment and accessories from third party products. The company generates a majority of its revenue from the propretaey product segment. Geographically, the firm operates in China.